Focus Partners Wealth’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
SCM
Focus Partners Wealth's ORGO Position: Q2 2026 in Review
Focus Partners Wealth opened a new position in Organogenesis Holdings (ORGO) in Q2 2026: 17,443 shares worth $42.4K. The stake represents ﹤0.01% of the portfolio and ranks #2689 among its holdings. This is a return to the name: Focus Partners Wealth previously reported a position in ORGO as recently as Q1 2025.
Focus Partners Wealth first reported a position in ORGO in Q3 2024 and has held it in 4 quarters since. The position peaked at $57.4K in Q1 2025. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.
- Focus Partners Wealth held 17,443 shares of Organogenesis Holdings worth $42.4K as of Q2 2026.
- Organogenesis Holdings was a new Focus Partners Wealth position in Q2 2026.
- Organogenesis Holdings made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #2689 holding.
- Focus Partners Wealth first reported a position in Organogenesis Holdings in Q3 2024 and has held it in 4 quarters since.
- Focus Partners Wealth's Organogenesis Holdings position peaked at $57.4K in Q1 2025.
- 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.
Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.